ClinicalTrials.Veeva

Menu
E

East View Medical Research, LLC. | Mobile, Alabama

Research site

Site insights

Top conditions

Top treatments

Upadacitinib
ABT-494
Vedolizumab
APT-1011
Risankizumab
Etrasimod
NG101
Vonoprazan
Lutikizumab
ABBV-154

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Auna Wallace

Verified by this site

Active trials

5 of 19 total trials

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433 (U-ENDURE)

A multicenter study to evaluate the efficacy and safety of maintenance and long-term treatment administration of upadacitinib, an orally administered...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Upadacitinib
Drug: Upadacitinib
Locations recently updated

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from...

Enrolling
Ulcerative Colitis
Crohn's Disease
Drug: Vedolizumab SC
Drug: Vedolizumab IV

Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large...

Enrolling
Ulcerative Colitis
Drug: Risankizumab
Drug: Vedolizumab

This study is designed to evaluate the long-term safety and efficacy of Upadacitinib in participants with ulcerative colitis (UC) who have not respon...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: Placebo
Drug: Upadacitinib (ABT-494)
Locations recently updated

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting...

Enrolling
Crohn's Disease
Drug: Risankizumab
Drug: Trosunilimab

Trial sponsors

AbbVie logo
E
Exact Sciences Corporation logo
A
N
Phathom Pharmaceuticals logo
Takeda logo
V

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems